Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 7
2022 20
2023 38
2024 129
2025 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Results by year

Citations

4 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). European Association for the Study of the Liver (EASL), et al. J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7. J Hepatol. 2024. PMID: 38851997 Free article.
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or …
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcohol …
Natural history and progression of metabolic dysfunction-associated steatotic liver disease.
Hagström H, Shang Y, Hegmar H, Nasr P. Hagström H, et al. Lancet Gastroenterol Hepatol. 2024 Oct;9(10):944-956. doi: 10.1016/S2468-1253(24)00193-6. Lancet Gastroenterol Hepatol. 2024. PMID: 39243773 Review.
The natural history of metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as non-alcoholic fatty liver disease (NAFLD), is complex and long. ...We highlight the dynamic pro …
The natural history of metabolic dysfunction-associated steatotic liver disease (MASLD), previously refer …
Natural history of metabolic dysfunction-associated steatotic liver disease.
Lekakis V, Papatheodoridis GV. Lekakis V, et al. Eur J Intern Med. 2024 Apr;122:3-10. doi: 10.1016/j.ejim.2023.11.005. Epub 2023 Nov 7. Eur J Intern Med. 2024. PMID: 37940495 Review.
Metabolic dysfunction-associated steatotic liver disease (MASLD), which has been the term for non-alcoholic fatty liver disease (NAFLD) since June 2023, represents the most common liver disease wo …
Metabolic dysfunction-associated steatotic liver disease (MASLD), which has been the term for non- …
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.
Targher G, Byrne CD, Tilg H. Targher G, et al. Gut. 2024 Mar 7;73(4):691-702. doi: 10.1136/gutjnl-2023-330595. Gut. 2024. PMID: 38228377 Review.
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic liver disease globally and is currently estimated to affect up to 38% of the global adult population. ...In 2023, three large multinational liv …
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic liver dise …
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.
Eslam M, El-Serag HB, Francque S, Sarin SK, Wei L, Bugianesi E, George J. Eslam M, et al. Nat Rev Gastroenterol Hepatol. 2022 Oct;19(10):638-651. doi: 10.1038/s41575-022-00635-5. Epub 2022 Jun 16. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35710982 Review.
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the global population; its burden has grown in parallel with rising rates of type 2 diabetes mellitus and obesity. MAFLD increases the risk …
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the global …
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).
Duseja A, Singh SP, De A, Madan K, Rao PN, Shukla A, Choudhuri G, Saigal S, Shalimar, Arora A, Anand AC, Das A, Kumar A, Eapen CE, Devadas K, Shenoy KT, Panigrahi M, Wadhawan M, Rathi M, Kumar M, Choudhary NS, Saraf N, Nath P, Kar S, Alam S, Shah S, Nijhawan S, Acharya SK, Aggarwal V, Saraswat VA, Chawla YK. Duseja A, et al. J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7. J Clin Exp Hepatol. 2023. PMID: 36950481 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease globally and in India. ...Given the high prevalence of NAFLD in the community, it is crucial to identify those at risk of progressive liver …
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease globally and in India. …
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). European Association for the Study of the Liver (EASL), et al. Obes Facts. 2024;17(4):374-444. doi: 10.1159/000539371. Epub 2024 Jun 7. Obes Facts. 2024. PMID: 38852583 Free PMC article.
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or …
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcohol …
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
European Association for the Study of the Liver; European Association for the Study of Diabetes; European Association for the Study of Obesity. European Association for the Study of the Liver, et al. Diabetologia. 2024 Nov;67(11):2375-2392. doi: 10.1007/s00125-024-06196-3. Diabetologia. 2024. PMID: 38869512 Free PMC article.
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or …
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcohol …
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.
Rivera-Esteban J, Muñoz-Martínez S, Higuera M, Sena E, Bermúdez-Ramos M, Bañares J, Martínez-Gomez M, Cusidó MS, Jiménez-Masip A, Francque SM, Tacke F, Minguez B, Pericàs JM. Rivera-Esteban J, et al. Clin Gastroenterol Hepatol. 2024 Sep;22(9):1774-1789.e8. doi: 10.1016/j.cgh.2024.03.028. Epub 2024 Apr 10. Clin Gastroenterol Hepatol. 2024. PMID: 38604295 Review.
Hepatocellular carcinoma (HCC) typically develops as a consequence of liver cirrhosis, but HCC epidemiology has evolved drastically in recent years. Metabolic dysfunction-associated steatotic liver disease (MASLD), including …
Hepatocellular carcinoma (HCC) typically develops as a consequence of liver cirrhosis, but HCC epidemiology has evolved …
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives.
Huang SC, Liu CJ. Huang SC, et al. Clin Mol Hepatol. 2023 Apr;29(2):320-331. doi: 10.3350/cmh.2022.0422. Epub 2023 Feb 1. Clin Mol Hepatol. 2023. PMID: 36726053 Free PMC article. Review.
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among the general population and chronic hepatitis B (CHB) patients worldwide. Although fatty liver disease is a well-known …
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among …
205 results